53 results
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:36pm
expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net:
Change in fair value … , research and development efforts, including clinical testing and regulatory approval, are required prior to commercialization of any potential product
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:35pm
expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net:
Change in fair value … , research and development efforts, including clinical testing and regulatory approval, are required prior to commercialization of any potential product
424B3
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Prospectus supplement
4:33pm
expenses:
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net:
Change in fair value … , research and development efforts, including clinical testing and regulatory approval, are required prior to commercialization of any potential product
8-K
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
9 Nov 23
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
4:31pm
LOSS
(unaudited)
Three Months Ended September 30,
Nine months ended September 30,
Revenue
Cost of revenue
Operating expenses:
Research … and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense), net:
Change in fair value of derivative warrant
424B3
gvtnqk
13 Sep 23
Prospectus supplement
4:30pm
S-3
re7e9bm
29 Aug 23
Shelf registration
4:31pm
DEF 14A
ioney9s
11 Aug 23
Definitive proxy
4:15pm
8-K
EX-99.1
7akz898nl 3mkke8
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
424B3
eqt3id
10 Aug 23
Prospectus supplement
4:37pm
424B3
tu9iphng2hzv6r1k
10 Aug 23
Prospectus supplement
4:32pm
424B3
at9mc
10 Aug 23
Prospectus supplement
4:32pm
PRE 14A
dqwx995bd7xfk
1 Aug 23
Preliminary proxy
5:08pm
424B3
hbqi1rzhc0ima
16 May 23
Prospectus supplement
4:33pm
424B3
4gzyobymwu
16 May 23
Prospectus supplement
4:31pm
424B3
83fpanrov957zxb9
16 May 23
Prospectus supplement
4:31pm
424B3
b1wgmc ku1wlb63a1
31 Mar 23
Prospectus supplement
4:34pm
424B3
u95dldksyfdidth
31 Mar 23
Prospectus supplement
4:34pm